Publication details

Pozdní ototoxicita cisplatiny u pacientů s meduloblastomem

Title in English Late Ototoxicity of Cisplatin in Patients with Medulloblastoma
Authors

HOŠNOVÁ Dagmar KEPÁK Tomáš BROŽ M.

Year of publication 2012
Type Article in Periodical
Magazine / Source Otorinolaryngologie a foniatrie
MU Faculty or unit

Faculty of Medicine

Citation
Field ORL, ophthalmology, stomatology
Keywords cisplatin; sensoric-neural hearing disorder; medulloblastoma; late consequences
Description Cisplatin is presently a widely used chemotherapeutic in many types of neoplasms. It causes various side effects, though. The literature indicates sensoric-neural hearing disorder as one of the side effects affecting more than 26% to 90% of patients according to the type of tumor, therapy and patient’s condition. The follow up of hearing is important not only during chemotherapy, when the change of therapeutic plan may prevent significant hearing loss, but also afterwards for late effects of cisplatin use.

You are running an old browser version. We recommend updating your browser to its latest version.

More info